These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 32558298)

  • 21. Analysis of appropriate duration of colchicine prophylaxis to maximize the persistence of xanthine oxidase inhibitors as the first-line urate-lowering therapy in patients with gout using the Korean Health Insurance Review and Assessment Service database.
    So MW; Kim AR; Lee SG
    Int J Rheum Dis; 2023 Sep; 26(9):1770-1778. PubMed ID: 37431263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risks and benefits of drugs used in the management and prevention of gout.
    Conaghan PG; Day RO
    Drug Saf; 1994 Oct; 11(4):252-8. PubMed ID: 7848545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Budget impact of adding lesinurad for second-line treatment of gout: a US health plan perspective.
    Klein RW; Kabadi S; Cinfio FN; Bly CA; Taylor DC; Szymanski KA
    J Comp Eff Res; 2018 Aug; 7(8):807-816. PubMed ID: 29792516
    [No Abstract]   [Full Text] [Related]  

  • 24. Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study.
    Schlesinger N; Mysler E; Lin HY; De Meulemeester M; Rovensky J; Arulmani U; Balfour A; Krammer G; Sallstig P; So A
    Ann Rheum Dis; 2011 Jul; 70(7):1264-71. PubMed ID: 21540198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Randomized, Double-Blind, Active- and Placebo-Controlled Efficacy and Safety Study of Arhalofenate for Reducing Flare in Patients With Gout.
    Poiley J; Steinberg AS; Choi YJ; Davis CS; Martin RL; McWherter CA; Boudes PF;
    Arthritis Rheumatol; 2016 Aug; 68(8):2027-34. PubMed ID: 26989892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new perspective on the pharmacoeconomics of colchicine.
    Wertheimer AI; Davis MW; Lauterio TJ
    Curr Med Res Opin; 2011 May; 27(5):931-7. PubMed ID: 21370937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colchicine prescribing in patients with gout.
    Dalbeth N; Gow P;
    N Z Med J; 2011 Jul; 124(1339):107-8. PubMed ID: 21952339
    [No Abstract]   [Full Text] [Related]  

  • 28. The Cost-effectiveness of Biannual Serum Urate (SU) Monitoring after Reaching Target in Gout: A Health Economic Analysis Comparing SU Monitoring.
    Robinson PC; Dalbeth N; Donovan P
    J Rheumatol; 2018 May; 45(5):697-704. PubMed ID: 29449500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Managing your patient with gout: a review of treatment options.
    Doghramji PP
    Postgrad Med; 2011 May; 123(3):56-71. PubMed ID: 21566416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Febuxostat compared with allopurinol in patients with hyperuricemia and gout.
    Becker MA; Schumacher HR; Wortmann RL; MacDonald PA; Eustace D; Palo WA; Streit J; Joseph-Ridge N
    N Engl J Med; 2005 Dec; 353(23):2450-61. PubMed ID: 16339094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Budget Impact of Increased Use of Febuxostat in the Management of Gout: A US Health Plan Managed Care Pharmacy and Medical Costs Perspective.
    Smolen LJ; Gahn JC; Mitri G; Shiozawa A
    Clin Ther; 2016 Jul; 38(7):1710-25. PubMed ID: 27269247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating appropriate use of prophylactic colchicine for gout flare prevention.
    George M; Pullman-Mooar S; Hussain F; Schumacher HR
    Arthritis Care Res (Hoboken); 2014 Aug; 66(8):1258-62. PubMed ID: 24376081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does starting allopurinol prolong acute treated gout? A randomized clinical trial.
    Hill EM; Sky K; Sit M; Collamer A; Higgs J
    J Clin Rheumatol; 2015 Apr; 21(3):120-5. PubMed ID: 25807090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cost-effectiveness of HLA-B*5801 screening to guide initial urate-lowering therapy for gout in the United States.
    Jutkowitz E; Dubreuil M; Lu N; Kuntz KM; Choi HK
    Semin Arthritis Rheum; 2017 Apr; 46(5):594-600. PubMed ID: 27916277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost effectiveness analysis of HLA-B*58:01 genotyping prior to initiation of allopurinol for gout.
    Plumpton CO; Alfirevic A; Pirmohamed M; Hughes DA
    Rheumatology (Oxford); 2017 Oct; 56(10):1729-1739. PubMed ID: 28957559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia.
    Huang X; Du H; Gu J; Zhao D; Jiang L; Li X; Zuo X; Liu Y; Li Z; Li X; Zhu P; Li J; Zhang Z; Huang A; Zhang Y; Bao C
    Int J Rheum Dis; 2014 Jul; 17(6):679-86. PubMed ID: 24467549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Managing gout: how is it different in patients with chronic kidney disease?
    El-Zawawy H; Mandell BF
    Cleve Clin J Med; 2010 Dec; 77(12):919-28. PubMed ID: 21147946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness analysis of HLA-B5801 genotyping in the treatment of gout patients with chronic renal insufficiency in Korea.
    Park DJ; Kang JH; Lee JW; Lee KE; Wen L; Kim TJ; Park YW; Park SH; Lee SS
    Arthritis Care Res (Hoboken); 2015 Feb; 67(2):280-7. PubMed ID: 25047754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A nurse-led, rheumatologist-assisted telemedicine intervention for dose escalation of urate-lowering therapy in gout.
    Phang KF; Santosa A; Low BPL; Tan PSH; Khong ZW; Lim AYN; Teng GG; Tay SH
    Int J Rheum Dis; 2020 Aug; 23(9):1136-1144. PubMed ID: 32483906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of colchicine and NSAID prophylaxis when initiating urate-lowering therapy for gout: propensity score-matched cohort studies in the UK Clinical Practice Research Datalink.
    Roddy E; Bajpai R; Forrester H; Partington RJ; Mallen CD; Clarson LE; Padmanabhan N; Whittle R; Muller S
    Ann Rheum Dis; 2023 Dec; 82(12):1618-1625. PubMed ID: 37788904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.